1. Keagle MB, Gersen SL, Basic laboratory procedures. In: Keagle MB, Gersen SL, eds. The Principles of Clinical Cytogenetics. Humana Press, Totowa, NJ; 2005:63–80.
2. Czepulkowski BH. Human cytogenetics: malignancy and acquired abnormalities; a practical approach. In: Rooney DE, ed. Oxford University Press, Oxford, England; 2001.
3. Shaffer LG, Tommerup N. International Standing Committee on Human Cytogenetic Nomenclature. ISCN 2005. Basel, Switzerland: Karger Press; 2005.
4. Brunning RD, Matutes E, Harris NL, et al. Acute myeloid leukaemia. In: Jaffe ES, Harris NL, World Health Organization, International Agency for Research on Cancer, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues: Who Classification of Tumours. IARC; 2001:75–91.
5. Vance GH, Kim H, Hicks GA, et al. Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900). Leuk Res. 2007;31:605–609.